N-[2-(1,3-benzothiazol-2-yl)-4-chlorophenyl]-2-chloropyridine-3-carboxamide
Structure Info
- Chemspace ID
- CSSB00121653907 (In-Stock Building Blocks)
- MFCD
- MFCD04151003
- IUPAC Name
- N-[2-(1,3-benzothiazol-2-yl)-4-chlorophenyl]-2-chloropyridine-3-carboxamide
- Mol formula
- C19H11Cl2N3OS
- Mol weight
- 400 Da
- Catalog Number(s)
- AA02O94J, AN-465/42250699, BS90703, CSC121653907, OSSK_780750, ST02OAO3, STK255161, STOCK7S-02626, TX02OACZ
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 5.44
- Heavy atoms count
- 26
- Rotatable bond count
- 3
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0
- Polar surface area (Å)
- 55
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
![Chemical structure of N-[2-(1,3-benzothiazol-2-yl)-4-chlorophenyl]-2-chloropyridine-3-carboxamide (C19H11Cl2N3OS) - CSSB00121653907](/st/structure/200/a084999cb4d402dc7e750f5d08eec5b1/ClC1%253DCC%253DC%2528NC%2528%253DO%2529C2%253DCC%253DCN%253DC2Cl%2529C%2528%253DC1%2529C1%253DNC2%253DCC%253DCC%253DC2S1.png "C19H11Cl2N3OS")
- Zoom the structure
- CSSB00121653907
Items Overall 3 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific LLC | 14 days | United States To: | 90 | 10 mg | 245.30 | |
| 1st Scientific LLC | 14 days | United States To: | 90 | 50 mg | 288.20 | |
| 1st Scientific LLC | 14 days | United States To: | 90 | 100 mg | 317.90 | |
Description: N-[2-(1,3-benzothiazol-2-yl)-4-chlorophenyl]-2-chloropyridine-3-carboxamide; CAS: 723752-70-3 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[2-(1,3-benzothiazol-2-yl)phenyl]-4-chlorobenzamide - CSSB00046239245](/st/structure/200/bf0f7364a2b0e9225e32c0aea17e263a/ClC1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529NC1%253DCC%253DCC%253DC1C1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of N-[2-(1,3-benzothiazol-2-yl)phenyl]-2-chlorobenzamide - CSSB00046208896](/st/structure/200/cd37417493bb6d35130f3e28b3ee1d00/ClC1%253DCC%253DCC%253DC1C%2528%253DO%2529NC1%253DCC%253DCC%253DC1C1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of N-[2-(1,3-benzothiazol-2-yl)phenyl]-2-bromobenzamide - CSSB00046130809](/st/structure/200/3cb9447415e88523498bb247fa8d423a/BrC1%253DCC%253DCC%253DC1C%2528%253DO%2529NC1%253DCC%253DCC%253DC1C1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of N-[3-(1,3-benzothiazol-2-yl)phenyl]-2,5-dichlorobenzamide - CSSB00121701220](/st/structure/200/496f0276953d9049e774b78319c4bd36/ClC1%253DCC%253DC%2528Cl%2529C%2528%253DC1%2529C%2528%253DO%2529NC1%253DCC%253DCC%2528%253DC1%2529C1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of N-[2-(1,3-benzothiazol-2-yl)phenyl]-2-phenylacetamide - CSSB00046514353](/st/structure/200/aab0661913505b3fdec33f6829bb7c10/O%253DC%2528CC1%253DCC%253DCC%253DC1%2529NC1%253DCC%253DCC%253DC1C1%253DNC2%253DCC%253DCC%253DC2S1.png)
